Insider Trading History of Ryan Barbara

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ryan Barbara since 2022. This trader's CIK number is 1827169. At the time of last reporting, Ryan Barbara was the Director of Indivior Pharmaceuticals, Inc.. (stock ticker symbol INDV). Also see all insider trading activities at Indivior Pharmaceuticals, Inc..

Note that in the past Ryan Barbara also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Mink Therapeutics, Inc. (INKT) by Ryan Barbara

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 INKT 0 $0 500 $5,425 0 $0

Yearly summary of insider trading at Invo Fertility, Inc. (INVO) by Ryan Barbara

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 INVO 10,526 $9,999 0 $0 0 $0

Yearly summary of insider trading at Indivior Pharmaceuticals, Inc. (INDV) by Ryan Barbara

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 INDV 814 $28,686 0 $0 0 $0


Insider trading activities at 3 companies by Ryan Barbara:

1. Mink Therapeutics, Inc. (INKT)

2. Invo Fertility, Inc. (INVO)

3. Indivior Pharmaceuticals, Inc. (INDV)

Table 1. Insider trading of Mink Therapeutics, Inc. (INKT) by Ryan Barbara

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-03-02 INKT Sale 100 10.83 1,082
2026-02-27 INKT Sale 400 10.86 4,343

Table 2. Insider trading of Invo Fertility, Inc. (INVO) by Ryan Barbara

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-06-01 INVO Buy 10,526 .95 9,999

Table 3. Insider trading of Indivior Pharmaceuticals, Inc. (INDV) by Ryan Barbara

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-03-13 INDV Buy 8 31.09 248
2026-03-09 INDV Buy 31 32.56 1,009
2026-01-05 INDV Buy 775 35.39 27,429

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ryan Barbara (Director of Indivior Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.